Further, in preeclampsia mouse models, nicotinamide (NAM, an NAD + precursor) administration normalized NAD + deficiency and prevented embryo growth restriction via placental mechanisms associated with inhibiting endothelin-1 receptor activation, improving endothelial function and perfusion [19, 42]. Here, EDNRA is linked to preeclampsia.